发明名称 TRICYCLIC-TYPE, HETEROCYCLIC DERIVATIVE COMPOUND, AND MEDICINE HAVING ITS COMPOUND AS EFFECTIVE COMPONENT
摘要 PROBLEM TO BE SOLVED: To provide a tricyclic-type, heterocyclic derivative compound which is useful as medicines and is expressed by general formula (I), and to provide a medicine having the compound as an effective component. SOLUTION: The medicine contains as an effective component a tricyclic-type, heterocyclic derivative compound expressed by general formula (I) and a pharmaceutically permissible salt thereof. In general formula (I), W, X and Y are each a carbon or nitrogen atom; U and Z are each CR<SP>2</SP>, NR<SP>13</SP>, a nitrogen-, oxygen-, sulfur-atom or the like; A ring is a carbon ring or a heterocyclic ring; R<SP>1</SP>is alkyl, alkenyl, alkinyl, NR<SP>4</SP>R<SP>5</SP>, OR<SP>6</SP>or the like; and R<SP>3</SP>is a carbon ring or a heterocyclic ring. The compound expressed by general formula (I) has an antagonistic action of a corticotropine releasing-factor receptor, so the compound is useful for prevention and/or cure against depression, anxiolytic disorder, ingestive abnormality, psychogenic post-traumatic stress, digestive ulcer, irritable colon syndrome, Alzheimer disease, withdrawal symptom from a drug or alcohol, and so on. COPYRIGHT: (C)2004,JPO
申请公布号 JP2004083597(A) 申请公布日期 2004.03.18
申请号 JP20030406938 申请日期 2003.12.05
申请人 ONO PHARMACEUT CO LTD 发明人 NAKAI HISAO;KAGAMIISHI YOSHIFUMI
分类号 C07D487/04;A61K31/519;A61P1/00;A61P1/04;A61P1/08;A61P1/10;A61P1/12;A61P1/14;A61P3/04;A61P3/08;A61P5/14;A61P9/00;A61P9/02;A61P9/04;A61P9/06;A61P9/10;A61P9/12;A61P11/06;A61P13/02;A61P17/06;A61P19/02;A61P19/10;A61P25/00;A61P25/04;A61P25/06;A61P25/08;A61P25/14;A61P25/16;A61P25/20;A61P25/22;A61P25/24;A61P25/28;A61P25/30;A61P25/32;A61P27/02;A61P29/00;A61P37/08;A61P43/00;C07D471/04;C07D487/14;C07D491/14;C07D491/147;C07D495/14;(IPC1-7):C07D487/04 主分类号 C07D487/04
代理机构 代理人
主权项
地址